US Stock MarketDetailed Quotes

REGENERATIVE MEDICAL TECHNOLOGY GRO (RMTG)

Watchlist
  • 0.0352
  • -0.0001-0.14%
15min DelayClose May 13 15:28 ET
463.02KMarket Cap-0.06P/E (TTM)

REGENERATIVE MEDICAL TECHNOLOGY GRO (RMTG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-174.64%-203.73K
-761.62%-598.09K
-47.11%57.11K
302.93%850.7K
1,390.45%379.39K
2,592.27%272.94K
122.23%90.4K
1,493.59%107.97K
62.37%-419.2K
40.22%-29.4K
Net income from continuing operations
-390.76%-4.35M
37.12%-1.31M
61.24%-760.04K
43.31%-5.56M
-149.26%-638.19K
84.85%-887.15K
-2.29%-2.08M
-17.41%-1.96M
-76.03%-9.81M
75.87%-256.04K
Operating gains losses
34,025.86%417.02K
-53.67%328
-23.30%1.15K
100.17%2.54K
99.94%-885
226.76%1.22K
170.94%708
134.12%1.5K
-11,150.24%-1.52M
-50,039.46%-1.51M
Depreciation and amortization
-14.35%76.08K
-33.91%54.83K
-32.33%51.81K
-28.88%220.56K
-128.69%-27.81K
-9.97%88.83K
43.36%82.97K
35.22%76.57K
103.03%310.1K
89.49%96.93K
Other non cash items
684.57%518.41K
-94.35%58.26K
-100.00%1
-30.51%2.13M
-99.43%4.39K
-91.36%66.08K
34.81%1.03M
33.79%1.02M
66.64%3.06M
47.99%764.61K
Change In working capital
212.61%3.14M
-43.51%594.27K
-20.90%764.19K
18.93%4.06M
18.76%1.04M
14.15%1M
31.24%1.05M
12.50%966.14K
37.49%3.42M
96.23%877.3K
-Change in receivables
-1,034.20%-77.33K
-205.45%-20.37K
132.22%6.3K
-94.77%1.35K
-24.01%8.4K
-141.96%-6.82K
-62.49%19.32K
63.11%-19.55K
179.39%25.81K
-69.71%11.06K
-Change in inventory
---50.2K
-1,140.40%-82.86K
---12.71K
---10.12K
---3.44K
--0
---6.68K
--0
--0
--0
-Change in prepaid assets
59.03%4.86M
371.70%32.5K
-450.72%-137.68K
-42.37%-29.19K
-20.47%-3.07M
21.01%3.06M
--6.89K
---25K
---20.5K
-20.80%-2.55M
-Change in payables and accrued expense
----
-35.59%665K
-10.28%908.28K
20.28%4.1M
----
----
37.65%1.03M
11.03%1.01M
35.51%3.41M
----
-Change in other current assets
---20K
--0
--0
---1.7K
--0
--0
--0
---1.7K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-174.64%-203.73K
-761.62%-598.09K
-47.10%57.11K
302.93%850.7K
1,390.50%379.39K
2,592.27%272.94K
122.23%90.4K
1,493.59%107.97K
62.37%-419.2K
40.52%-29.4K
Investing cash flow
Cash flow from continuing investing activities
-319.39%-224.83K
-110.00%-110.58K
0
44.13%-215.42K
82.39%-50K
41.34%-53.61K
-1,015.38%-52.66K
-978.27%-59.15K
-94.33%-385.6K
-314.44%-284K
Net PPE purchase and sale
-319.39%-224.83K
-110.00%-110.58K
--0
44.13%-215.42K
82.39%-50K
41.34%-53.61K
-1,015.38%-52.66K
-978.27%-59.15K
-94.33%-385.6K
-314.44%-284K
Cash from discontinued investing activities
Investing cash flow
-319.39%-224.83K
-110.00%-110.58K
--0
44.13%-215.42K
82.39%-50K
41.34%-53.61K
-1,015.38%-52.66K
-978.27%-59.15K
-94.33%-385.6K
-314.44%-284K
Financing cash flow
Cash flow from continuing financing activities
0
0
0
0
0
0
-1,391.38%-309.85K
-4,519.65%-300K
Net issuance payments of debt
--0
----
----
--0
--0
--0
--0
--0
-1,391.38%-309.85K
-4,519.65%-300K
Cash from discontinued financing activities
Financing cash flow
--0
--1.1M
--0
--0
--0
--0
--0
--0
-1,391.38%-309.85K
-4,519.65%-300K
Net cash flow
Beginning cash position
161.59%1.61M
111.09%1.22M
119.74%1.17M
-67.75%530.54K
-26.88%836.43K
-49.63%617.09K
-64.60%579.35K
-67.75%530.54K
-44.77%1.65M
-35.36%1.14M
Current changes in cash
-295.39%-428.56K
936.87%391.33K
17.00%57.11K
156.99%635.28K
153.70%329.39K
369.95%219.33K
109.17%37.74K
670.17%48.81K
16.40%-1.11M
-392.89%-613.4K
End cash Position
41.76%1.19M
161.59%1.61M
111.09%1.22M
119.74%1.17M
119.74%1.17M
-26.88%836.43K
-49.63%617.09K
-64.60%579.35K
-67.75%530.54K
-67.75%530.54K
Free cash flow
-295.39%-428.56K
-1,977.73%-708.68K
17.00%57.11K
178.94%635.28K
205.10%329.39K
369.95%219.33K
109.17%37.74K
3,686.81%48.81K
38.69%-804.8K
-165.69%-313.4K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -174.64%-203.73K-761.62%-598.09K-47.11%57.11K302.93%850.7K1,390.45%379.39K2,592.27%272.94K122.23%90.4K1,493.59%107.97K62.37%-419.2K40.22%-29.4K
Net income from continuing operations -390.76%-4.35M37.12%-1.31M61.24%-760.04K43.31%-5.56M-149.26%-638.19K84.85%-887.15K-2.29%-2.08M-17.41%-1.96M-76.03%-9.81M75.87%-256.04K
Operating gains losses 34,025.86%417.02K-53.67%328-23.30%1.15K100.17%2.54K99.94%-885226.76%1.22K170.94%708134.12%1.5K-11,150.24%-1.52M-50,039.46%-1.51M
Depreciation and amortization -14.35%76.08K-33.91%54.83K-32.33%51.81K-28.88%220.56K-128.69%-27.81K-9.97%88.83K43.36%82.97K35.22%76.57K103.03%310.1K89.49%96.93K
Other non cash items 684.57%518.41K-94.35%58.26K-100.00%1-30.51%2.13M-99.43%4.39K-91.36%66.08K34.81%1.03M33.79%1.02M66.64%3.06M47.99%764.61K
Change In working capital 212.61%3.14M-43.51%594.27K-20.90%764.19K18.93%4.06M18.76%1.04M14.15%1M31.24%1.05M12.50%966.14K37.49%3.42M96.23%877.3K
-Change in receivables -1,034.20%-77.33K-205.45%-20.37K132.22%6.3K-94.77%1.35K-24.01%8.4K-141.96%-6.82K-62.49%19.32K63.11%-19.55K179.39%25.81K-69.71%11.06K
-Change in inventory ---50.2K-1,140.40%-82.86K---12.71K---10.12K---3.44K--0---6.68K--0--0--0
-Change in prepaid assets 59.03%4.86M371.70%32.5K-450.72%-137.68K-42.37%-29.19K-20.47%-3.07M21.01%3.06M--6.89K---25K---20.5K-20.80%-2.55M
-Change in payables and accrued expense -----35.59%665K-10.28%908.28K20.28%4.1M--------37.65%1.03M11.03%1.01M35.51%3.41M----
-Change in other current assets ---20K--0--0---1.7K--0--0--0---1.7K--0--0
Cash from discontinued investing activities
Operating cash flow -174.64%-203.73K-761.62%-598.09K-47.10%57.11K302.93%850.7K1,390.50%379.39K2,592.27%272.94K122.23%90.4K1,493.59%107.97K62.37%-419.2K40.52%-29.4K
Investing cash flow
Cash flow from continuing investing activities -319.39%-224.83K-110.00%-110.58K044.13%-215.42K82.39%-50K41.34%-53.61K-1,015.38%-52.66K-978.27%-59.15K-94.33%-385.6K-314.44%-284K
Net PPE purchase and sale -319.39%-224.83K-110.00%-110.58K--044.13%-215.42K82.39%-50K41.34%-53.61K-1,015.38%-52.66K-978.27%-59.15K-94.33%-385.6K-314.44%-284K
Cash from discontinued investing activities
Investing cash flow -319.39%-224.83K-110.00%-110.58K--044.13%-215.42K82.39%-50K41.34%-53.61K-1,015.38%-52.66K-978.27%-59.15K-94.33%-385.6K-314.44%-284K
Financing cash flow
Cash flow from continuing financing activities 000000-1,391.38%-309.85K-4,519.65%-300K
Net issuance payments of debt --0----------0--0--0--0--0-1,391.38%-309.85K-4,519.65%-300K
Cash from discontinued financing activities
Financing cash flow --0--1.1M--0--0--0--0--0--0-1,391.38%-309.85K-4,519.65%-300K
Net cash flow
Beginning cash position 161.59%1.61M111.09%1.22M119.74%1.17M-67.75%530.54K-26.88%836.43K-49.63%617.09K-64.60%579.35K-67.75%530.54K-44.77%1.65M-35.36%1.14M
Current changes in cash -295.39%-428.56K936.87%391.33K17.00%57.11K156.99%635.28K153.70%329.39K369.95%219.33K109.17%37.74K670.17%48.81K16.40%-1.11M-392.89%-613.4K
End cash Position 41.76%1.19M161.59%1.61M111.09%1.22M119.74%1.17M119.74%1.17M-26.88%836.43K-49.63%617.09K-64.60%579.35K-67.75%530.54K-67.75%530.54K
Free cash flow -295.39%-428.56K-1,977.73%-708.68K17.00%57.11K178.94%635.28K205.10%329.39K369.95%219.33K109.17%37.74K3,686.81%48.81K38.69%-804.8K-165.69%-313.4K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More